Literature DB >> 31823615

Self-Delivery Micellar Nanoparticles Prevent Premetastatic Niche Formation by Interfering with the Early Recruitment and Vascular Destruction of Granulocytic Myeloid-Derived Suppressor Cells.

Yang Long1, Zhengze Lu1, Shanshan Xu1, Man Li1, Xuhui Wang1, Zhirong Zhang1, Qin He1.   

Abstract

Distal metastases of tumors result from the interaction between "seeds" (circulating tumor cells, CTCs) and "soil" (premetastatic niche, PMN). Various strategies focus on CTC inhibition, but only a few strategies inhibit PMN formation. The main predisposition of PMN formation in melanoma lies in the pulmonary recruitment of granulocytic myeloid-derived suppressor cells (G-MDSCs, CD11b+Ly6G+ cells) induced by tumors, which increase vascular permeability by secreting matrix metalloproteinase-9 (MMP-9) and result in immunosuppression by secreting interleukin-10 (IL-10) in premetastatic lungs. Here, a micellar hypotoxic low molecular weight heparin-tocopherol succinate nanoparticle (LMWH-TOS nanoparticle, LT NP) was established and investigated for its influence on PMN formation in this study. We first demonstrated that the hydrophilic segment LMWH in LT NPs can inhibit early pulmonary recruitment of G-MDSCs through interrupting their extravasation by inhibiting P-selectin/PSGL-1-mediated adhesion between vascular endothelial cells and G-MDSCs. In addition, the hydrophobic segment (TOS) in LT NPs significantly inhibited the expression of MMP-9 in G-MDSCs. As a result, the drug-free nanoparticles could maintain the normal microenvironment of lungs, thus effectively inhibiting implantation and colonization of CTCs. Further, phenylboronic acid (PBA)-modified and doxorubicin/immunopotentiator α-galactosylceramide (αGC)-coloaded nanoparticles (PLT/DOX/αGC NPs) were exploited. PBA modification achieved targeted chemotherapy by binding to overexpressed sialic acid residues on the tumor cell surface. This nanosystem effectively inhibited the postoperative metastasis and tumor recurrence simultaneously. Our work provides a proof of concept that the prevention of PMN formation through interfering G-MDSCs with self-delivery nanosystems is a safe and effective antimetastasis strategy.

Entities:  

Keywords:  LMWH; Self-delivery nanoparticles; TOS; circulating tumor cells; postoperative metastasis and recurrence of tumors; premetastatic niche

Mesh:

Substances:

Year:  2019        PMID: 31823615     DOI: 10.1021/acs.nanolett.9b03883

Source DB:  PubMed          Journal:  Nano Lett        ISSN: 1530-6984            Impact factor:   11.189


  11 in total

1.  Inflammation-targeted cannabidiol-loaded nanomicelles for enhanced oral mucositis treatment.

Authors:  Yingke Liu; Xingying Qi; Yashi Wang; Man Li; Quan Yuan; Zhihe Zhao
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

2.  Fucoidan-functionalized activated platelet-hitchhiking micelles simultaneously track tumor cells and remodel the immunosuppressive microenvironment for efficient metastatic cancer treatment.

Authors:  Rong Guo; Miao Deng; Xuan He; Mengmeng Li; Jiaxin Li; Penghui He; Houqin Liu; Man Li; Zhirong Zhang; Qin He
Journal:  Acta Pharm Sin B       Date:  2021-06-16       Impact factor: 11.413

3.  Multifunctional self-delivery micelles targeting the invasion-metastasis cascade for enhanced chemotherapy against melanoma and the lung metastasis.

Authors:  Shanshan Xu; Chunyu Liu; Shuya Zang; Jiaxin Li; Yashi Wang; Kebai Ren; Man Li; Zhirong Zhang; Qin He
Journal:  Asian J Pharm Sci       Date:  2021-09-16       Impact factor: 6.598

Review 4.  Characteristics of pre-metastatic niche: the landscape of molecular and cellular pathways.

Authors:  Hao Wang; Junjie Pan; Livnat Barsky; Jule Caroline Jacob; Yan Zheng; Chao Gao; Shun Wang; Wenwei Zhu; Haoting Sun; Lu Lu; Huliang Jia; Yue Zhao; Christiane Bruns; Razi Vago; Qiongzhu Dong; Lunxiu Qin
Journal:  Mol Biomed       Date:  2021-01-30

Review 5.  Nanotechnology-enhanced immunotherapy for metastatic cancer.

Authors:  Peisen Zhang; Junli Meng; Yingying Li; Chen Yang; Yi Hou; Wen Tang; Kevin J McHugh; Lihong Jing
Journal:  Innovation (Camb)       Date:  2021-10-14

Review 6.  The Role of the Innate Immune System in Cancer Dormancy and Relapse.

Authors:  Noah M Chernosky; Ilaria Tamagno
Journal:  Cancers (Basel)       Date:  2021-11-10       Impact factor: 6.639

7.  Systemic metastasis-targeted nanotherapeutic reinforces tumor surgical resection and chemotherapy.

Authors:  Minjun Xu; Kaili Hu; Yipu Liu; Yukun Huang; Shanshan Liu; Yu Chen; Dayuan Wang; Songlei Zhou; Qian Zhang; Ni Mei; Huiping Lu; Fengan Li; Xiaoling Gao; Jun Chen
Journal:  Nat Commun       Date:  2021-05-27       Impact factor: 14.919

Review 8.  Myeloid-Derived Suppressor Cells: Implications in the Resistance of Malignant Tumors to T Cell-Based Immunotherapy.

Authors:  Houhui Shi; Kai Li; Yanghong Ni; Xiao Liang; Xia Zhao
Journal:  Front Cell Dev Biol       Date:  2021-07-14

Review 9.  Recent Advancements in Nanomedicine for 'Cold' Tumor Immunotherapy.

Authors:  Qinjun Chen; Tao Sun; Chen Jiang
Journal:  Nanomicro Lett       Date:  2021-03-16

Review 10.  Tumor Targeted Nanocarriers for Immunotherapy.

Authors:  Alejandro Baeza
Journal:  Molecules       Date:  2020-03-26       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.